These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2760187)

  • 1. Is Wilson's disease a dementing condition?
    Lang C
    J Clin Exp Neuropsychol; 1989 Aug; 11(4):569-70. PubMed ID: 2760187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Wilson's disease, a reversible dementia: case report.
    Rosselli M; Lorenzana P; Rosselli A; Vergara I
    J Clin Exp Neuropsychol; 1987 Aug; 9(4):399-406. PubMed ID: 3597731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effect of penicillamine on the mental disorders associated with wilson's disease (author's transl)].
    Hach B; Hartung ML
    Nervenarzt; 1979 Feb; 50(2):115-20. PubMed ID: 424037
    [No Abstract]   [Full Text] [Related]  

  • 4. Memory deficits in Wilson's disease: a response to Lang.
    Medalia A
    J Clin Exp Neuropsychol; 1991 Mar; 13(2):359-60. PubMed ID: 1864920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [On hepatolenticular degeneration (Wilson's disease). II. Treatment of 2 cases of Wilson's disease for 8 months with D-penicillamine].
    Germinario L; Campanella G; D'Addabbo A
    Acta Neurol (Napoli); 1971; 26(4):423-35. PubMed ID: 5132824
    [No Abstract]   [Full Text] [Related]  

  • 6. Wilson's disease and mental disturbances.
    Vitorovic S; Lieina M
    Can J Psychiatry; 1996 Mar; 41(2):132-3. PubMed ID: 8705963
    [No Abstract]   [Full Text] [Related]  

  • 7. Neurological abnormalities in Wilson's disease are reversible.
    Lingam S; Wilson J; Nazer H; Mowat AP
    Neuropediatrics; 1987 Feb; 18(1):11-2. PubMed ID: 3561699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypothyroidism and dyshormonogenesis induced by D-penicillamine in children with Wilson's disease and healthy infants born to a mother with Wilson's disease.
    Hanukoglu A; Curiel B; Berkowitz D; Levine A; Sack J; Lorberboym M
    J Pediatr; 2008 Dec; 153(6):864-6. PubMed ID: 19014823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychosis in an adolescent patient with Wilson's disease: effects of chelation therapy.
    McDonald LV; Lake CR
    Psychosom Med; 1995; 57(2):202-4. PubMed ID: 7792379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pregnancy and delivery in a woman with Wilson's disease (degeneratio hepatoleuticularis)].
    Pierzchała W; Zamłyński J; Rzempołuch J
    Pol Tyg Lek; 1994 Feb 21-28; 49(8-9):200-1. PubMed ID: 8084826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Recent findings in the therapy of Wilson's disease].
    Rigardetto R; Trevisio A
    Minerva Pediatr; 1975 Feb; 27(3):177-86. PubMed ID: 1226193
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hepatolenticular degeneration, Wilson's disease. A characteristics case with remission under penicillamine therapy].
    Hansen J; Andersen OS
    Ugeskr Laeger; 1969 Jul; 131(31):1306-9. PubMed ID: 5824791
    [No Abstract]   [Full Text] [Related]  

  • 13. [What is your diagnosis? Wilson's disease (hepatolenticular degeneration)].
    Keller DH
    Schweiz Rundsch Med Prax; 1993 Mar; 82(12):337-8. PubMed ID: 8465128
    [No Abstract]   [Full Text] [Related]  

  • 14. Patient with late-onset Wilson's disease: deterioration with penicillamine.
    Sohtaoglu M; Ergin H; Ozekmekçi S; Gökdemir S; Sonsuz A; Arici C
    Mov Disord; 2007 Jan; 22(2):290-1. PubMed ID: 17083099
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of penicillamine and zinc on iron metabolism in Wilson's disease.
    Medici V; Di Leo V; Lamboglia F; Bowlus CL; Tseng SC; D'Incà R; Irato P; Burra P; Martines D; Sturniolo GC
    Scand J Gastroenterol; 2007 Dec; 42(12):1495-500. PubMed ID: 17994470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discontinuation of penicillamine in the absence of alternative orphan drugs (trientine-zinc): a case of decompensated liver cirrhosis in Wilson's disease.
    Ping CC; Hassan Y; Aziz NA; Ghazali R; Awaisu A
    J Clin Pharm Ther; 2007 Feb; 32(1):101-7. PubMed ID: 17286794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatolenticular degeneration (Wilson's disease).
    Wis Med J; 1970 Mar; 69(3):105-10. PubMed ID: 5434427
    [No Abstract]   [Full Text] [Related]  

  • 18. [Pathogenesis and treatment of Wilson's disease].
    Nagy J; Vincze Z; Folhoffer A; Horváth A; Csák T; Zelkó R
    Acta Pharm Hung; 2003; 73(4):237-41. PubMed ID: 15279036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wilson's disease. Psychiatric manifestations may be the clinical presentation.
    Jackson GH; Meyer A; Lippmann S
    Postgrad Med; 1994 Jun; 95(8):135-8. PubMed ID: 8202418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zinc therapy increases duodenal concentrations of metallothionein and iron in Wilson's disease patients.
    Sturniolo GC; Mestriner C; Irato P; Albergoni V; Longo G; D'Incà R
    Am J Gastroenterol; 1999 Feb; 94(2):334-8. PubMed ID: 10022625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.